Dextran Sodium Sulphate-Induced Gastrointestinal Injury Further Aggravates the Impact of Galantamine on the Gastric Myoelectric Activity in Experimental Pigs

Dextran Sodium Sulphate-Induced Gastrointestinal Injury Further Aggravates the Impact of Galantamine on the Gastric Myoelectric Activity in Experimental Pigs

Galantamine has been used as a treatment for Alzheimer disease. It has a unique, dual mode of action (inhibitor of acetylcholinesterase and allosteric modulator of nicotinic acetylcholine receptors). Nausea (in about 20%), vomiting (10%) and diarrhoea (5–7%) are the most common side effects. The aim...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Jan Bures, Ilja Tacheci, Jaroslav Kvetina, Vera Radochova, Darina Kohoutova, Martin Valis, Stanislav Rejchrt, Veronika Knoblochova, Jana Zdarova Karasova
Formatua: Artikulua
Hizkuntza:English
Argitaratua: MDPI AG 2021-06-01
Saila:Pharmaceuticals
Gaiak:
Alzheimer disease
galantamine
electrogastrography
experimental pigs
gastric motor dysmotility
small bowel transit time
Sarrera elektronikoa:https://www.mdpi.com/1424-8247/14/6/590

Internet

https://www.mdpi.com/1424-8247/14/6/590

Antzeko izenburuak